Investors are asking harder questions. Boards want measurable impact. Customers expect intelligent products, not AI labels.
So don’t get stuck in your ways as you age. Castel writes in his book that even changing up your old habits — hiking a ...
Ahead of the full data release and FDA regulatory decision, doctors and researchers parse the limitations of clinical trials ...